Retinal Edema
Retinal Edema - Related Videos
01:18
Pulmonary Edema II: Pathophysiology
0 Views •
2026
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:22
Cerebral Edema ll: Pathophysiology
0 Views •
2026
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:21
Cytotoxic Edema: Pathophysiology
0 Views •
2026
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
03:16
Intravenous Delivery of Receptor Blockers to Reduce Brain Edema in a Mouse Model
0 Views •
2025
Source: Zeynalov, E. et. al., Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema. J. Vis. Exp. (2016)This video demonstrates the intravenous delivery of an arginine-vasopressin (AVP) receptor antagonist in a mouse model. Transient middle cerebral artery occlusion induces brain edema. An AVP receptor antagonist is administered through a catheter in the left jugular vein, alleviating edema.
01:19
Cerebral Edema l: Introduction
0 Views •
2026
Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
FAQs
Barrier failure permits fluid and proteins to escape from retinal vessels and enter neural retinal tissue. The resulting swelling can change the local organization of retinal circuitry, meaning the networks that process visual information no longer operate under normal tissue conditions. If photoreceptors are damaged, the retina’s ability to convert light into visual signals may decline, contributing to reduced visual acuity.
The effects extend beyond the blood vessels because the retina is neural tissue, not merely a passive vascular surface. Fluid accumulation can distort the circuitry that carries and processes visual information, while photoreceptor injury can compromise light detection. This connection explains why studies of retinal edema examine both vascular barrier integrity and the functional consequences for visual acuity.
Anti-vascular endothelial growth factor therapy focuses on the vascular component by targeting vascular leakage. By reducing the leakage associated with the condition, this approach may limit fluid accumulation and help preserve or improve visual function. Its significance is therefore mechanistic as well as therapeutic: it links a molecular vascular target to the neural outcome of vision.
Optical coherence tomography, or OCT, is used to detect and monitor retinal edema over time. In research and assessment, repeated imaging can show whether swelling changes as the condition progresses or after treatment. This makes OCT valuable for connecting structural changes in retinal tissue with visual outcomes, without treating the image itself as a direct measure of neural function.
It is especially relevant when investigators study how vascular changes affect neural tissue and visual processing. Because the retina converts light into visual signals, edema provides a model in which barrier disruption, tissue swelling, photoreceptor injury, and reduced visual acuity can be considered together. Research can therefore connect vascular pathology with changes in sensory function.
Treatment evaluation considers whether vascular leakage and swelling are reduced and whether visual function is preserved or improved. OCT can monitor retinal changes, while visual acuity provides an important functional outcome. Using both measures helps researchers relate tissue-level effects to the condition’s impact on vision.